“CID” CRE8 EVO Sirolimus eluting Carbofilm coated coronary stent on rapid exchange balloon catheter - Taiwan Registration 5d80df078005d888e1d2c98e97376400
Access comprehensive regulatory information for “CID” CRE8 EVO Sirolimus eluting Carbofilm coated coronary stent on rapid exchange balloon catheter in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 5d80df078005d888e1d2c98e97376400 and manufactured by CID S.P.A.. The authorized representative in Taiwan is CHAICO INVESTMENT CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
5d80df078005d888e1d2c98e97376400
Ministry of Health Medical Device Import No. 035007
DHA05603500700
Product Details
Details are as detailed as approved Chinese instructions
E Cardiovascular devices
E0001 Cardiovascular stents
Imports outside the borders;; Safety monitoring
Dates and Status
Oct 25, 2021
Oct 25, 2026

